— Know what they know.
Not Investment Advice
Also trades as: BDXB (NYSE) · $vol 22M · 0R19.L (LSE) · $vol 1M · BDX.SW (SIX) · BDXA (NYSE)

BDX NYSE

Becton, Dickinson and Company
1W: +1.3% 1M: -6.0% 3M: -21.1% YTD: -4.5% 1Y: -15.8% 3Y: -38.6% 5Y: -33.1%
$147.63
+1.38 (+0.94%)
 
Weekly Expected Move ±5.0%
$129 $136 $143 $151 $158
NYSE · Healthcare · Medical - Instruments & Supplies · Alpha Radar Sell · Power 38 · $53.5B mcap · 362M float · 0.802% daily turnover · Short 49% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NARROW EDGE
56.2 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 4.2%  ·  5Y Avg: 3.8%
Cost Advantage
56
Intangibles
51
Switching Cost
54
Network Effect
50
Scale ★
75
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. BDX has a Narrow competitive edge (56.2/100) — meaningful but not impregnable advantages over competitors. The primary source of advantage is Efficient Scale. ROIC of 4.2% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$204
Low
$204
Avg Target
$204
High
Based on 1 analyst since May 7, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 16Hold: 17Sell: 1Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$176.25
Analysts4
Consensus Change History
DateFieldFromTo
2026-05-06 consensus Buy Hold
2026-02-10 consensus Hold Buy
2026-01-06 consensus Buy Hold
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-11 Barclays $202 $204 +2 +36.5% $149.43
2026-04-17 Piper Sandler Jason Bednar $170 $159 -11 +2.7% $154.82
2026-04-14 RBC Capital $172 $175 +3 +12.6% $155.43
2026-04-10 Goldman Sachs David Roman $274 $167 -107 +8.1% $154.42
2026-02-10 RBC Capital Shagun Singh $210 $172 -38 +1.1% $170.14
2026-02-10 Barclays Matt Miksic $312 $202 -110 -2.6% $207.39
2026-02-10 Piper Sandler $205 $170 -35 -18.0% $207.39
2026-01-28 Piper Sandler Jason Bednar $260 $205 -55 +28.2% $159.91
2026-01-07 Stifel Nicolaus $280 $215 -65 +33.2% $161.45
2025-12-17 RBC Capital Initiated $210 +36.0% $154.39
2025-12-02 Morgan Stanley Patrick Wood $290 $210 -80 +39.3% $150.80
2025-04-23 Piper Sandler Jason Bednar $255 $260 +5 +63.5% $159.06
2024-10-01 Evercore ISI Vijay Kumar $285 $290 +5 +53.0% $189.54
2024-10-01 Citigroup Joanna Wuensch $250 $275 +25 +44.6% $190.20
2024-08-02 Raymond James Jayson Bedford Initiated $270 +43.6% $187.96
2024-08-02 Wells Fargo Larry Biegelsen $295 $280 -15 +50.9% $185.54
2024-07-02 Evercore ISI Becton Dickinson Initiated $285 +58.1% $180.24
2024-05-30 Goldman Sachs David Roman $272 $274 +2 +54.9% $176.94
2024-05-06 Barclays Matt Miksic Initiated $312 +69.1% $184.50
2024-04-08 Argus Research David Toung Initiated $300 +57.2% $190.83
2023-01-06 Morgan Stanley $272 $290 +18 +42.9% $202.92
2022-12-12 Citigroup $235 $250 +15 +28.4% $194.65
2022-11-23 Goldman Sachs $319 $272 -47 +46.3% $185.90
2022-08-16 Goldman Sachs Initiated $319 +51.9% $210.01
2022-07-18 Stifel Nicolaus Initiated $280 +49.4% $187.40
2022-07-15 Morgan Stanley $282 $272 -10 +45.0% $187.61
2022-07-11 Citigroup Initiated $235 +21.7% $193.13
2022-06-25 Wells Fargo Larry Biegelsen Initiated $295 +49.5% $197.26
2022-05-06 Morgan Stanley Initiated $282 +42.5% $197.95
2022-05-06 Piper Sandler $265 $255 -10 +24.9% $204.12
2022-03-02 Bank of America Securities Travis Steed Initiated $290 +38.6% $209.27
2022-02-02 Piper Sandler Jason Bednar Initiated $265 +28.2% $206.71

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B
May 22, 2026
DCF
5
ROE
3
ROA
4
D/E
1
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. BDX receives an overall rating of B. Strongest factors: DCF (5/5), ROA (4/5). Areas of concern: D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-11 B+ B
2026-03-02 B B+
2026-02-17 B+ B
2026-02-09 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

44 Grade B
Profitability
20
Balance Sheet
40
Earnings Quality
76
Growth
22
Value
46
Momentum
56
Safety
50
Cash Flow
66
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. BDX scores highest in Earnings Quality (76/100) and lowest in Profitability (20/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.85
Grey Zone
Piotroski F-Score
6/9
Beneish M-Score
-2.76
Unlikely Manipulator
Ohlson O-Score
-8.29
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BB+
Score: 46.2/100
Trend: Stable
Earnings Quality
100/100
OCF/NI: 3.43x
Accruals: -4.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. BDX scores 1.85, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. BDX scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. BDX's score of -2.76 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. BDX's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. BDX receives an estimated rating of BB+ (score: 46.2/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). BDX's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
36.41x
PEG
-1.47x
P/S
2.50x
P/B
1.72x
P/FCF
14.04x
P/OCF
11.31x
EV/EBITDA
15.00x
EV/Revenue
2.92x
EV/EBIT
27.12x
EV/FCF
19.87x
Earnings Yield
2.58%
FCF Yield
7.12%
Shareholder Yield
3.25%
Graham Number
$90.85
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 36.4x earnings, BDX commands a growth premium. Graham's intrinsic value formula yields $90.85 per share, 62% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.654
NI / EBT
×
Interest Burden
0.755
EBT / EBIT
×
EBIT Margin
0.108
EBIT / Rev
×
Asset Turnover
0.379
Rev / Assets
×
Equity Multiplier
2.196
Assets / Equity
=
ROE
4.4%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. BDX's ROE of 4.4% is driven by Asset Turnover (0.379), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$34.47
Price/Value
4.56x
Margin of Safety
-356.17%
Premium
356.17%
Assessment
Overvalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with BDX's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. BDX trades at a 356% premium to its adjusted intrinsic value of $34.47, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 8.5x compares to the current market P/E of 36.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$147.64
Median 1Y
$135.07
5th Pctile
$87.43
95th Pctile
$209.20
Ann. Volatility
27.0%
Analyst Target
$176.25
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Thomas E. Polen
Chairman, Chief Executive Officer and President
$1,395,463 $9,991,854 $17,129,140
Christopher J. DelOrefice
Executive Vice President and Chief Financial Officer
$837,500 $3,140,481 $5,877,164
Michael C. Feld
Executive Vice President, Chief Revenue Officer and President, Life Sciences Segment
$775,000 $1,641,596 $4,096,356
Michael D. Garrison
Executive Vice President and President, Medical Essentials and BioPharma Systems Segments
$768,750 $1,641,596 $3,649,040
Richard E. Byrd
Executive Vice President and President, Interventional Segment
$756,250 $1,427,531 $3,399,056

CEO Pay Ratio

234:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $17,129,140
Avg Employee Cost (SGA/emp): $73,292
Employees: 72,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
72,000
-2.7% YoY
Revenue / Employee
$303,319
Rev: $21,839,000,000
Profit / Employee
$23,306
NI: $1,678,000,000
SGA / Employee
$73,292
Avg labor cost proxy
R&D / Employee
$17,556
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 8.7% 8.8% 7.4% 8.1% 7.4% 7.3% 6.6% 6.6% 6.8% 5.8% 4.9% 5.2% 5.5% 6.7% 6.8% 5.9% 6.2% 6.5% 6.9% 4.4% 4.44%
ROA 3.7% 3.9% 3.3% 3.6% 3.3% 3.3% 3.0% 3.0% 3.1% 2.8% 2.4% 2.5% 2.7% 3.1% 3.2% 2.8% 2.9% 3.0% 3.1% 2.0% 2.02%
ROIC 5.8% 6.4% 5.4% 5.6% 5.5% 5.2% 5.1% 5.2% 5.2% 4.8% 4.1% 4.3% 4.6% 5.0% 5.3% 4.9% 5.2% 5.3% 5.3% 4.2% 4.21%
ROCE 5.1% 5.4% 4.2% 4.5% 4.5% 4.8% 4.6% 4.8% 5.0% 4.6% 4.3% 4.6% 4.7% 5.3% 5.3% 4.8% 5.2% 5.3% 5.6% 4.9% 4.90%
Gross Margin 42.5% 44.5% 47.1% 44.5% 44.5% 43.6% 46.5% 46.4% 43.1% 33.4% 43.1% 45.7% 46.2% 46.3% 43.2% 42.8% 47.8% 47.5% 44.6% 45.7% 45.69%
Operating Margin 10.7% 9.6% 14.7% 11.9% 11.6% 10.3% 12.8% 13.0% 11.3% 6.9% 9.3% 14.5% 12.1% 15.1% 8.8% 10.4% 16.0% 11.8% 11.3% 2.0% 1.99%
Net Margin 11.4% 5.2% 14.3% 9.6% 7.8% 6.0% 11.1% 9.5% 8.3% 2.1% 6.0% 10.6% 9.8% 7.7% 5.9% 5.8% 10.4% 8.4% 7.3% -6.6% -6.60%
EBITDA Margin 22.3% 18.9% 26.4% 22.9% 23.1% 21.1% 25.1% 25.1% 23.8% 17.3% 21.9% 26.3% 24.1% 21.0% 20.7% 21.3% 26.7% 22.0% 23.0% 4.0% 4.01%
FCF Margin 21.4% 17.1% 13.5% 9.9% 7.7% 8.8% 7.3% 6.1% 9.1% 10.9% 13.6% 15.3% 16.2% 15.2% 14.2% 12.4% 11.9% 12.2% 12.0% 14.7% 14.71%
OCF Margin 26.4% 23.3% 19.6% 15.8% 13.6% 14.0% 12.6% 11.2% 13.8% 15.4% 17.6% 19.1% 19.9% 18.8% 17.7% 15.8% 15.2% 15.7% 15.5% 18.3% 18.26%
ROE 3Y Avg snapshot only 5.17%
ROE 5Y Avg snapshot only 6.01%
ROA 3Y Avg snapshot only 2.41%
ROIC 3Y Avg snapshot only 3.16%
ROIC Economic snapshot only 4.17%
Cash ROA snapshot only 7.05%
Cash ROIC snapshot only 8.92%
CROIC snapshot only 7.19%
NOPAT Margin snapshot only 8.62%
Pretax Margin snapshot only 8.14%
R&D / Revenue snapshot only 5.55%
SGA / Revenue snapshot only 24.95%
SBC / Revenue snapshot only -0.86%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio 32.89 30.81 37.23 36.39 37.98 33.91 42.71 41.62 43.64 48.88 54.45 52.09 46.58 39.54 36.89 42.88 30.63 31.85 31.49 38.77 36.407
P/S Ratio 3.28 3.23 3.39 3.64 3.47 3.20 3.67 3.58 3.81 3.74 3.51 3.52 3.32 3.38 3.12 3.12 2.30 2.45 2.52 2.07 2.503
P/B Ratio 2.71 2.72 2.78 2.95 2.82 2.39 2.72 2.66 2.87 2.81 2.65 2.69 2.55 2.64 2.49 2.52 1.90 2.11 2.18 1.74 1.717
P/FCF 15.31 18.87 25.14 36.85 44.75 36.34 50.37 58.43 41.74 34.30 25.83 22.94 20.43 22.21 21.96 25.15 19.29 20.02 21.03 14.04 14.044
P/OCF 12.42 13.87 17.36 22.97 25.52 22.91 29.17 32.07 27.56 24.27 19.94 18.46 16.68 17.97 17.67 19.74 15.12 15.58 16.30 11.31 11.311
EV/EBITDA 17.02 16.57 19.17 19.69 18.75 17.09 19.43 18.55 19.37 19.76 19.34 19.06 18.05 18.32 17.38 18.32 13.98 14.48 14.45 15.00 14.997
EV/Revenue 4.05 4.00 4.19 4.44 4.26 3.99 4.47 4.38 4.60 4.49 4.25 4.25 4.05 4.27 3.99 3.98 3.14 3.29 3.36 2.92 2.923
EV/EBIT 32.23 30.99 40.59 40.45 38.43 34.56 40.59 37.88 39.07 41.15 41.40 39.72 37.18 33.65 32.29 35.98 26.57 28.77 28.02 27.12 27.116
EV/FCF 18.91 23.35 31.00 44.93 55.03 45.41 61.39 71.49 50.39 41.13 31.28 27.72 24.91 28.05 28.08 32.08 26.33 26.88 27.99 19.87 19.875
Earnings Yield 3.0% 3.2% 2.7% 2.7% 2.6% 2.9% 2.3% 2.4% 2.3% 2.0% 1.8% 1.9% 2.1% 2.5% 2.7% 2.3% 3.3% 3.1% 3.2% 2.6% 2.58%
FCF Yield 6.5% 5.3% 4.0% 2.7% 2.2% 2.8% 2.0% 1.7% 2.4% 2.9% 3.9% 4.4% 4.9% 4.5% 4.6% 4.0% 5.2% 5.0% 4.8% 7.1% 7.12%
EV/OCF snapshot only 16.008
EV/Gross Profit snapshot only 6.289
Acquirers Multiple snapshot only 27.546
Shareholder Yield snapshot only 3.25%
Graham Number snapshot only $90.85
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 1.54 1.33 1.33 1.33 1.33 1.04 1.04 1.04 1.04 1.31 1.31 1.31 1.31 1.17 1.17 1.17 1.17 1.11 1.11 1.11 1.113
Quick Ratio 1.07 0.92 0.92 0.92 0.92 0.63 0.63 0.63 0.63 0.81 0.81 0.81 0.81 0.74 0.74 0.74 0.74 0.64 0.64 0.64 0.645
Debt/Equity 0.75 0.74 0.74 0.74 0.74 0.64 0.64 0.64 0.64 0.62 0.62 0.62 0.62 0.78 0.78 0.78 0.78 0.76 0.76 0.76 0.755
Net Debt/Equity 0.63 0.65 0.65 0.65 0.65 0.60 0.60 0.60 0.60 0.56 0.56 0.56 0.56 0.69 0.69 0.69 0.69 0.72 0.72 0.72 0.722
Debt/Assets 0.33 0.33 0.33 0.33 0.33 0.30 0.30 0.30 0.30 0.30 0.30 0.30 0.30 0.35 0.35 0.35 0.35 0.35 0.35 0.35 0.347
Debt/EBITDA 3.84 3.66 4.17 4.07 4.03 3.64 3.72 3.62 3.55 3.61 3.71 3.61 3.57 4.27 4.24 4.43 4.19 3.87 3.76 4.61 4.606
Net Debt/EBITDA 3.23 3.18 3.62 3.54 3.50 3.41 3.49 3.39 3.33 3.28 3.37 3.28 3.25 3.81 3.78 3.96 3.74 3.70 3.59 4.40 4.400
Interest Coverage 5.13 5.50 4.46 5.00 5.27 5.48 5.14 5.14 5.07 4.68 4.34 4.51 4.44 4.85 4.46 3.86 4.12 4.07 4.65 4.09 4.091
Equity Multiplier 2.27 2.28 2.28 2.28 2.28 2.09 2.09 2.09 2.09 2.05 2.05 2.05 2.05 2.21 2.21 2.21 2.21 2.18 2.18 2.18 2.179
Cash Ratio snapshot only 0.103
Debt Service Coverage snapshot only 7.396
Cash to Debt snapshot only 0.045
FCF to Debt snapshot only 0.164
Defensive Interval snapshot only 183.5 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.37 0.37 0.36 0.36 0.36 0.35 0.35 0.35 0.36 0.37 0.37 0.37 0.38 0.37 0.38 0.38 0.39 0.39 0.39 0.38 0.379
Inventory Turnover 3.93 3.92 3.88 3.88 3.85 3.48 3.47 3.45 3.52 3.45 3.52 3.57 3.54 3.10 3.17 3.25 3.30 3.08 3.07 2.96 2.956
Receivables Turnover 8.27 8.41 8.16 8.09 8.11 8.31 8.25 8.28 8.39 8.20 8.25 8.35 8.39 7.25 7.42 7.50 7.68 7.25 7.27 7.09 7.090
Payables Turnover 8.56 6.94 6.89 6.87 6.82 6.05 6.02 5.99 6.11 6.71 6.84 6.94 6.88 6.23 6.38 6.53 6.64 6.16 6.14 5.91 5.910
DSO 44 43 45 45 45 44 44 44 44 45 44 44 43 50 49 49 48 50 50 51 51.5 days
DIO 93 93 94 94 95 105 105 106 104 106 104 102 103 118 115 112 111 119 119 123 123.5 days
DPO 43 53 53 53 53 60 61 61 60 54 53 53 53 59 57 56 55 59 59 62 61.8 days
Cash Conversion Cycle 94 84 86 86 86 88 89 89 87 96 95 93 94 110 107 105 103 110 110 113 113.2 days
Fixed Asset Turnover snapshot only 3.053
Operating Cycle snapshot only 175.0 days
Cash Velocity snapshot only 24.872
Capital Intensity snapshot only 2.590
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 15.9% 16.6% 6.4% 1.9% -1.9% -5.5% -3.2% -2.1% -1.0% 2.7% 4.0% 4.8% 4.1% 4.2% 5.9% 5.8% 7.9% 8.2% 6.2% 2.4% 2.39%
Net Income 1.2% 1.4% 10.4% 11.9% -10.2% -15.0% -8.8% -15.8% -5.2% -16.6% -22.0% -17.6% -15.1% 16.3% 39.2% 14.0% 13.7% -2.8% 0.5% -25.1% -25.08%
EPS 1.1% 1.4% 12.8% 14.4% -8.7% -14.4% -8.3% -15.3% -5.5% -18.3% -23.7% -18.9% -15.8% 17.1% 39.7% 14.4% 14.3% -1.6% 2.4% -22.8% -22.80%
FCF 69.8% 25.2% -24.7% -54.3% -64.5% -51.4% -47.8% -39.3% 16.8% 27.4% 93.9% 1.6% 85.2% 45.3% 10.9% -14.4% -20.9% -13.1% -10.4% 21.3% 21.31%
EBITDA 31.8% 31.3% -4.7% -4.9% -6.2% -8.4% 2.1% 2.6% 3.5% -0.2% -0.8% -0.8% -1.8% 6.9% 10.7% 3.0% 8.1% 5.3% 7.5% -8.2% -8.20%
Op. Income 80.7% 79.4% -5.0% -2.0% -5.5% -14.3% 2.9% -0.2% -1.6% -7.5% -9.7% -7.5% -5.6% 22.9% 32.8% 16.9% 27.2% -0.7% 4.2% -6.4% -6.36%
OCF Growth snapshot only 18.25%
Asset Growth snapshot only -3.42%
Equity Growth snapshot only -1.93%
Debt Growth snapshot only -4.62%
Shares Change snapshot only -2.96%
Dividend Growth snapshot only 3.04%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 10.0% 7.7% 4.3% 4.1% 4.0% 3.0% 2.6% 2.6% 4.0% 4.2% 2.3% 1.5% 0.4% 0.4% 2.1% 2.8% 3.6% 5.0% 5.4% 4.3% 4.34%
Revenue 5Y 9.8% 9.8% 9.3% 9.3% 9.6% 9.3% 8.9% 6.9% 5.3% 3.9% 2.7% 3.0% 3.0% 3.1% 3.5% 3.7% 4.8% 5.0% 3.8% 2.5% 2.52%
EPS 3Y 33.4% 84.3% 17.3% 18.7% 21.5% 11.5% 19.4% 13.2% 21.9% 19.3% -7.6% -7.7% -10.1% -6.4% -0.8% -7.7% -3.1% -2.0% 3.0% -10.5% -10.52%
EPS 5Y 5.0% 10.1% 0.5% 2.1% 11.2% 5.6% 26.4% 1.0% 15.4% 34.4% 2.5% 2.8% 7.4% 5.8% 12.7% 6.1% 11.8% 14.4% 2.5% -7.1% -7.05%
Net Income 3Y 36.2% 88.8% 19.1% 21.2% 23.4% 13.0% 20.9% 14.6% 22.3% 19.3% -7.8% -8.1% -10.3% -6.2% -0.3% -7.5% -2.9% -1.9% 2.9% -11.1% -11.05%
Net Income 5Y 11.4% 16.5% 6.2% 7.9% 17.3% 10.1% 31.9% 1.0% 16.6% 36.7% 3.7% 4.3% 8.6% 7.0% 13.9% 7.2% 12.1% 13.9% 1.9% -7.9% -7.89%
EBITDA 3Y 10.4% 7.7% -3.9% -3.1% -1.3% 2.6% 5.5% 5.2% 8.5% 6.3% -1.2% -1.1% -1.6% -0.8% 3.9% 1.6% 3.2% 4.0% 5.7% -2.1% -2.11%
EBITDA 5Y 10.7% 13.3% 7.3% 8.1% 14.8% 11.3% 15.6% 15.9% 5.5% 2.7% -2.1% -1.5% -0.5% 2.9% 5.2% 3.5% 6.3% 6.2% 2.8% -1.8% -1.77%
Gross Profit 3Y 10.8% 8.3% 4.3% 2.1% 2.3% 0.8% 0.4% 1.9% 3.8% 2.5% -1.1% -2.8% -3.0% -0.3% 2.4% 2.8% 3.5% 5.4% 6.1% 5.3% 5.27%
Gross Profit 5Y 9.3% 9.0% 7.6% 7.5% 7.9% 7.4% 6.8% 6.5% 4.9% 2.4% 1.0% 0.2% 0.6% 2.0% 2.5% 3.0% 4.8% 5.5% 3.8% 2.3% 2.34%
Op. Income 3Y 20.7% 21.0% -0.7% 2.1% 1.0% 9.0% 16.5% 11.7% 18.9% 12.5% -4.0% -3.3% -4.3% -0.8% 7.3% 2.6% 5.7% 4.1% 7.7% 0.4% 0.42%
Op. Income 5Y 8.3% 13.2% 2.3% 3.7% 15.2% 9.1% 19.3% 28.4% 10.3% 7.0% -1.8% -0.3% -0.9% 8.1% 13.7% 8.5% 15.0% 11.7% 4.1% -0.2% -0.18%
FCF 3Y 31.7% 20.1% 11.1% -1.9% -14.2% -11.2% -21.6% -22.8% -11.0% -8.1% -8.7% -10.0% -8.4% -3.5% 3.9% 10.9% 19.6% 17.2% 24.4% 39.7% 39.72%
FCF 5Y 17.3% 13.2% 8.7% 0.4% 1.7% -1.9% -5.0% -7.3% -1.1% 1.4% 6.8% 8.5% 6.4% 5.3% 0.7% 0.6% 0.6% -0.4% -5.4% -5.4% -5.41%
OCF 3Y 24.5% 17.5% 10.7% 1.9% -7.2% -7.5% -14.7% -15.7% -8.4% -5.5% -7.7% -9.4% -8.7% -6.5% -1.2% 2.7% 7.6% 9.2% 12.9% 22.9% 22.95%
OCF 5Y 15.4% 12.7% 9.4% 3.4% 4.2% 0.6% -1.6% -3.7% -0.4% 0.9% 4.2% 5.5% 3.9% 2.7% -0.8% -1.2% -1.0% -0.6% -4.9% -5.1% -5.08%
Assets 3Y 12.7% -0.0% -0.0% -0.0% -0.0% 0.7% 0.7% 0.7% 0.7% -0.8% -0.8% -0.8% -0.8% 2.1% 2.1% 2.1% 2.1% 1.5% 1.5% 1.5% 1.48%
Assets 5Y 15.0% 16.1% 16.1% 16.1% 16.1% 7.0% 7.0% 7.0% 7.0% -0.4% -0.4% -0.4% -0.4% 2.0% 2.0% 2.0% 2.0% 0.5% 0.5% 0.5% 0.48%
Equity 3Y 22.4% 4.1% 4.1% 4.1% 4.1% 6.2% 6.2% 6.2% 6.2% 2.8% 2.8% 2.8% 2.8% 3.0% 3.0% 3.0% 3.0% 0.1% 0.1% 0.1% 0.14%
Book Value 3Y 19.9% 1.6% 2.6% 1.9% 2.5% 4.8% 4.9% 4.9% 5.9% 2.8% 3.0% 3.1% 3.0% 2.8% 2.6% 2.8% 2.9% 0.1% 0.2% 0.7% 0.73%
Dividend 3Y -1.4% -1.7% -0.9% -1.7% -0.6% -0.3% -0.1% 0.1% 1.1% 1.0% 0.7% 0.3% -0.7% -0.7% 0.1% 1.2% 2.3% 2.8% 1.9% 1.6% 1.60%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.95 0.94 0.91 0.91 0.89 0.83 0.82 0.82 0.79 0.72 0.82 0.81 0.65 0.63 0.84 0.90 0.92 0.97 0.90 0.83 0.829
Earnings Stability 0.30 0.29 0.38 0.43 0.72 0.49 0.81 0.75 0.68 0.53 0.26 0.23 0.30 0.24 0.23 0.02 0.07 0.12 0.01 0.71 0.708
Margin Stability 0.98 0.97 0.96 0.97 0.97 0.96 0.96 0.98 0.98 0.97 0.96 0.95 0.95 0.95 0.95 0.96 0.97 0.97 0.96 0.95 0.950
Rev. Growth Consistency 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 1.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.96 0.95 0.96 0.94 0.96 0.94 0.98 0.93 0.91 0.93 0.94 0.93 0.84 0.94 0.95 0.99 1.00 0.90 0.900
Earnings Smoothness 0.27 0.18 0.90 0.89 0.89 0.84 0.91 0.83 0.95 0.82 0.75 0.81 0.84 0.85 0.67 0.87 0.87 0.97 0.99 0.71 0.713
ROE Trend 0.04 0.04 0.02 0.02 0.01 0.01 -0.01 -0.01 -0.01 -0.02 -0.02 -0.02 -0.02 0.00 0.01 0.00 0.00 0.00 0.01 -0.01 -0.010
Gross Margin Trend 0.00 0.00 -0.02 -0.02 -0.01 -0.00 -0.01 -0.01 -0.01 -0.03 -0.04 -0.04 -0.03 0.02 0.02 0.01 0.02 0.02 0.02 0.04 0.035
FCF Margin Trend 0.07 0.02 -0.04 -0.08 -0.10 -0.08 -0.09 -0.10 -0.05 -0.02 0.03 0.07 0.08 0.05 0.04 0.02 -0.01 -0.01 -0.02 0.01 0.008
Sustainable Growth Rate 4.1% 4.4% 3.0% 3.6% 2.9% 2.8% 2.1% 2.1% 2.2% 1.4% 0.6% 0.9% 1.3% 2.4% 2.4% 1.4% 1.7% 1.9% 2.2% -0.2% -0.18%
Internal Growth Rate 1.8% 2.0% 1.3% 1.6% 1.3% 1.3% 1.0% 1.0% 1.0% 0.7% 0.3% 0.4% 0.6% 1.2% 1.1% 0.7% 0.8% 0.9% 1.0%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 2.65 2.22 2.14 1.58 1.49 1.48 1.46 1.30 1.58 2.01 2.73 2.82 2.79 2.20 2.09 2.17 2.03 2.04 1.93 3.43 3.428
FCF/OCF 0.81 0.74 0.69 0.62 0.57 0.63 0.58 0.55 0.66 0.71 0.77 0.80 0.82 0.81 0.80 0.79 0.78 0.78 0.78 0.81 0.805
FCF/Net Income snapshot only 2.761
OCF/EBITDA snapshot only 0.937
CapEx/Revenue 5.0% 6.2% 6.1% 6.0% 5.8% 5.2% 5.3% 5.0% 4.7% 4.5% 4.0% 3.7% 3.6% 3.6% 3.5% 3.4% 3.3% 3.5% 3.5% 3.6% 3.55%
CapEx/Depreciation snapshot only 0.408
Accruals Ratio -0.06 -0.05 -0.04 -0.02 -0.02 -0.02 -0.01 -0.01 -0.02 -0.03 -0.04 -0.05 -0.05 -0.04 -0.03 -0.03 -0.03 -0.03 -0.03 -0.05 -0.049
Sloan Accruals snapshot only -0.043
Cash Flow Adequacy snapshot only 2.007
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield 1.6% 1.6% 1.6% 1.5% 1.6% 1.8% 1.6% 1.6% 1.5% 1.5% 1.6% 1.6% 1.7% 1.6% 1.7% 1.8% 2.4% 2.2% 2.2% 2.7% 2.38%
Dividend/Share $3.57 $3.63 $3.68 $3.69 $3.73 $3.78 $3.83 $3.86 $3.89 $3.81 $3.80 $3.79 $3.76 $3.79 $3.88 $3.98 $4.07 $4.17 $4.18 $4.22 $3.51
Payout Ratio 53.3% 50.1% 59.7% 55.2% 61.0% 60.8% 67.8% 68.3% 67.2% 75.1% 88.2% 82.6% 77.1% 63.7% 64.5% 75.7% 73.1% 71.3% 67.9% 1.0% 1.04%
FCF Payout Ratio 24.8% 30.7% 40.3% 55.9% 71.9% 65.2% 79.9% 95.8% 64.3% 52.7% 41.8% 36.4% 33.8% 35.8% 38.4% 44.4% 46.0% 44.8% 45.3% 37.7% 37.71%
Total Payout Ratio 1.0% 1.3% 1.6% 1.5% 1.0% 88.9% 98.8% 99.2% 97.3% 75.1% 1.3% 1.2% 1.1% 63.7% 78.8% 92.2% 88.7% 1.3% 96.4% 1.3% 1.26%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 0 0 0 1 0 0 0 1 1 0
Chowder Number 0.04 0.04 0.03 0.03 0.04 0.05 0.05 0.06 0.06 0.04 0.03 0.01 -0.01 0.00 0.03 0.06 0.10 0.11 0.08 0.06 0.057
Buyback Yield 1.6% 2.7% 2.7% 2.5% 1.1% 0.8% 0.7% 0.7% 0.7% 0.0% 0.7% 0.7% 0.8% 0.0% 0.4% 0.4% 0.5% 1.9% 0.9% 0.6% 0.57%
Net Buyback Yield 1.6% 2.7% 2.7% 2.5% 1.1% 0.8% 0.7% 0.7% 0.7% 0.0% 0.7% 0.7% 0.8% 0.0% 0.4% 0.4% 0.5% 1.9% 0.9% 0.6% 0.57%
Total Shareholder Return 3.2% 4.3% 4.3% 4.0% 2.7% 2.6% 2.3% 2.4% 2.2% 1.5% 2.4% 2.3% 2.4% 1.6% 2.1% 2.1% 2.9% 4.1% 3.1% 3.3% 3.25%
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.99 0.99 1.14 1.14 1.02 1.00 0.97 0.92 0.92 0.89 0.82 0.81 0.84 0.85 0.88 0.89 0.84 0.89 0.85 0.65 0.654
Interest Burden (EBT/EBIT) 0.81 0.82 0.78 0.80 0.81 0.82 0.81 0.81 0.80 0.79 0.77 0.78 0.77 0.79 0.78 0.74 0.76 0.75 0.79 0.76 0.755
EBIT Margin 0.13 0.13 0.10 0.11 0.11 0.12 0.11 0.12 0.12 0.11 0.10 0.11 0.11 0.13 0.12 0.11 0.12 0.11 0.12 0.11 0.108
Asset Turnover 0.37 0.37 0.36 0.36 0.36 0.35 0.35 0.35 0.36 0.37 0.37 0.37 0.38 0.37 0.38 0.38 0.39 0.39 0.39 0.38 0.379
Equity Multiplier 2.36 2.27 2.27 2.27 2.27 2.18 2.18 2.18 2.18 2.07 2.07 2.07 2.07 2.13 2.13 2.13 2.13 2.20 2.20 2.20 2.196
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $6.70 $7.25 $6.16 $6.69 $6.11 $6.21 $5.65 $5.66 $5.78 $5.07 $4.31 $4.59 $4.87 $5.94 $6.02 $5.25 $5.56 $5.84 $6.16 $4.06 $4.06
Book Value/Share $81.42 $82.04 $82.58 $82.41 $82.41 $88.22 $88.60 $88.51 $87.80 $88.13 $88.53 $88.85 $88.88 $89.09 $89.15 $89.52 $89.68 $88.43 $89.06 $90.47 $85.99
Tangible Book/Share $-46.82 $-45.02 $-45.32 $-45.22 $-45.22 $-40.65 $-40.82 $-40.78 $-40.45 $-33.04 $-33.19 $-33.31 $-33.32 $-39.55 $-39.58 $-39.74 $-39.81 $-37.01 $-37.28 $-37.87 $-37.87
Revenue/Share $67.19 $69.18 $67.55 $66.86 $66.98 $65.85 $65.67 $65.85 $66.14 $66.18 $66.89 $67.91 $68.31 $69.44 $71.08 $72.16 $74.08 $76.06 $76.90 $76.13 $76.13
FCF/Share $14.38 $11.84 $9.12 $6.60 $5.19 $5.79 $4.79 $4.03 $6.04 $7.23 $9.09 $10.42 $11.10 $10.57 $10.11 $8.96 $8.83 $9.30 $9.23 $11.20 $11.20
OCF/Share $17.74 $16.10 $13.21 $10.60 $9.10 $9.19 $8.27 $7.35 $9.15 $10.21 $11.77 $12.95 $13.59 $13.07 $12.57 $11.41 $11.27 $11.95 $11.91 $13.90 $13.90
Cash/Share $9.75 $7.95 $8.00 $7.99 $7.99 $3.54 $3.55 $3.55 $3.52 $4.87 $4.89 $4.90 $4.91 $7.44 $7.45 $7.48 $7.49 $2.99 $3.01 $3.06 $2.91
EBITDA/Share $15.98 $16.68 $14.75 $15.06 $15.22 $15.39 $15.13 $15.54 $15.72 $15.04 $14.70 $15.16 $15.32 $16.19 $16.33 $15.69 $16.64 $17.26 $17.88 $14.84 $14.84
Debt/Share $61.43 $61.02 $61.42 $61.30 $61.30 $56.06 $56.30 $56.24 $55.79 $54.25 $54.49 $54.69 $54.71 $69.20 $69.25 $69.54 $69.66 $66.81 $67.28 $68.35 $68.35
Net Debt/Share $51.68 $53.07 $53.41 $53.31 $53.31 $52.52 $52.75 $52.69 $52.27 $49.38 $49.61 $49.79 $49.80 $61.76 $61.81 $62.06 $62.17 $63.81 $64.27 $65.29 $65.29
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score 1.849
Altman Z-Prime snapshot only 2.919
Piotroski F-Score 7 6 6 6 5 4 4 5 3 5 5 5 6 7 8 7 8 6 7 6 6
Beneish M-Score -2.72 -2.70 -2.64 -2.59 -2.59 -2.60 -2.61 -2.61 -2.60 -2.31 -2.50 -2.55 -2.61 -2.61 -2.45 -2.40 -2.44 -2.66 -2.67 -2.76 -2.764
Ohlson O-Score snapshot only -8.294
Net-Net WC snapshot only $-73.69
EVA snapshot only $-2530484646.35
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only BB+
Credit Score 53.65 50.11 46.15 49.94 49.79 50.77 50.34 49.94 51.06 54.20 50.15 55.17 51.34 46.95 46.69 46.82 46.54 47.58 48.19 46.24 46.240
Credit Grade snapshot only 11
Credit Trend snapshot only -0.584
Implied Spread (bps) snapshot only 400.000
Industry Credit Rank snapshot only 29
Sector Credit Rank snapshot only 42

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms